Tamoxifen citrate AC SGK3 degrader-1 AZD2014 shows consistent exposure in

AZD2014 shows consistent exposure in rodents and a low turnover in human hepatocyte incubations

InChi: InChI=1S/C46H47ClN10O8S/c1-24-25(2)66-46-40(24)41(27-11-13-28(47)14-12-27)50-33(43-55-52-26(3)57(43)46)21-38(59)48-17-6-7-18-49-39(60)23-65-42-35(63-4)19-29(20-36(42)64-5)53-54-32-10-8-9-30-31(32)22-56(45(30)62)34-15-16-37(58)51-44(34)61/h8-14

de Haven Brandon AK

Chemical Name: 3-N-(1-Propylbenzimidazol-2-yl)benzene-1

Tamoxifen citrate AC SGK3 degrader-1 AZD2014 shows consistent exposure inTamoxifen, also known as ICI 46474, is an antagonist of the estrogen receptor in breast tissue via its active metabolite, 4 hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a selective estrogen receptor modulator. Tamoxifen is the usual endocrine (anti estrogen) therapy for hormone receptor positive breast cancer in pre menopausal women, and is also a standard in post menopausal